Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting the epigenome in malignant melanoma: Facts, challenges and therapeutic promises.

Pharmacology & therapeutics·2022
Same author

Tumor microenvironment, immune response and post-radiotherapy tumor clearance.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2020
Same author

Expression of autophagy-related proteins Beclin-1 and LC3A and proliferation marker Ki-67 in calculous and acalculous human gallbladder epithelium.

Hippokratia·2020
Same author

Characterization of the "Autophagic Flux" in Prostate Cancer Tissue Biopsies by LC3A/LAMP2a Immunofluorescence and Confocal Microscopy.

Methods in molecular biology (Clifton, N.J.)·2019
Same author

Presentation of a patient with in situ amelanotic melanoma of the vulva.

European journal of gynaecological oncology·2018
Same author

Blood vessels and cancer much more than just angiogenesis.

Cell death discovery·2016

Related Experiment Video

Updated: Jul 16, 2026

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation
07:17

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation

Published on: August 23, 2024

BNIP3 expression in follicular lymphoma.

J Sington1, A Giatromanolaki, L Campo

  • 1Nuffield Department of Clinical Laboratory Sciences, University of Oxford, John Radcliffe Hospital, Oxford, UK.

Histopathology
|March 31, 2007
PubMed
Summary

BNIP3 protein is highly expressed in most follicular lymphomas, unlike in reactive cases. This finding suggests BNIP3 may indicate more aggressive lymphoma behavior and aid in diagnosis.

More Related Videos

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
09:14

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Published on: September 28, 2022

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
09:52

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia

Published on: December 4, 2018

Related Experiment Videos

Last Updated: Jul 16, 2026

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation
07:17

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation

Published on: August 23, 2024

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
09:14

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Published on: September 28, 2022

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
09:52

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia

Published on: December 4, 2018

Area of Science:

  • Oncology
  • Molecular Biology
  • Pathology

Background:

  • Follicular lymphoma is a common non-Hodgkin lymphoma.
  • Bcl-2 family proteins play critical roles in apoptosis and cell survival.
  • BNIP3 is a Bcl-2 interacting protein with poorly understood functions in lymphoma.

Purpose of the Study:

  • To investigate the expression of BNIP3 in follicular lymphoma (FL) compared to reactive lymphoid hyperplasia (RLH).
  • To assess the relationship between BNIP3 expression and Bcl-2, p53, caspase-3, and Ki67.
  • To determine if BNIP3 can serve as a diagnostic marker for FL.

Main Methods:

  • Immunohistochemistry was performed on follicular lymphoma and reactive lymphoid hyperplasia samples.
  • Monoclonal antibodies were used to detect BNIP3, Bcl-2, p53, caspase-3, and Ki67.
  • Expression levels were quantified and compared between groups.

Main Results:

  • BNIP3 showed strong expression in most follicular lymphomas but was weak or negative in reactive lymphoid hyperplasia.
  • BNIP3 expression was inversely related to Bcl-2 expression.
  • No correlation was found between BNIP3 and proliferation markers (Ki67), p53, or caspase-3.

Conclusions:

  • BNIP3 is significantly upregulated in follicular lymphoma, particularly in Bcl-2 negative cases.
  • BNIP3 may be a marker for more aggressive behavior in follicular lymphoma.
  • BNIP3 could be a useful diagnostic marker to differentiate FL from RLH.